Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pureland Global Venture (PGV) is a private investment group based in Singapore, founded in 2014. As part of the broader Pureland Group, PGV operates as a direct investment fund with a focus on impact investments in the medical technology sector. The firm targets early-stage companies that aim to enhance patient care and address gaps in healthcare supply and demand, primarily in the Asia-Pacific region, India, and the United States.
Currently, Pureland Global Venture employs a team of 12 professionals and has established itself as a significant player in the medical technology investment space. The firm is recognized for its dual fund structure, with Fund I focusing on capital preservation in secondary markets and Fund II dedicated to impact-driven venture capital investments in medtech. The firm has received institutional endorsement as a co-investment partner from Enterprise Singapore, enhancing its credibility within the Singapore startup ecosystem.
Pureland Global Venture specializes in investments within the medical technology sector, with a particular emphasis on AI solutions and medical devices. The firm seeks to enhance affordability and effectiveness for emerging markets, improve clinical efficiency, and provide innovative therapeutic solutions. Notably, Pureland Global Venture does not invest in biomedical sciences or pharmaceutical drug discovery startups.
The fund primarily targets early-stage companies, focusing on seed to Series A investments. Its geographic allocation is approximately 60% in the United States and 40% across Singapore, India, and Europe. The investment thesis centers on delivering impactful medical solutions that improve patient care and address healthcare challenges in underserved markets.
Pureland Global Venture maintains a diverse portfolio that spans over ten different sectors globally, although specific portfolio companies are not publicly listed. Notable investments include:
Portfolio companies are backed by prestigious organizations, including the Gates Foundation, Stanford University, and the American College of Cardiology. The firm’s investments cover various therapeutic areas, including oncology, ophthalmology, brain health, orthopedics, cardiology, and chronic disease management.
Mark Wang - Partner. Mark has a background in venture capital and has been instrumental in shaping the investment strategy at Pureland Global Venture. His expertise lies in identifying impactful medical technology solutions.
Eiffel Sun - Team member with experience in healthcare investments. Eiffel contributes to the firm's due diligence and portfolio management processes.
Hong Shaoming - Team member focused on market analysis and investment strategy. Hong plays a key role in evaluating potential investment opportunities.
Rayson Tan - Team member with a background in technology and healthcare. Rayson assists in assessing the technological viability of potential investments.
Zhang Heng - Team member involved in operational support for portfolio companies. Zhang helps startups optimize their clinical workflows and market strategies.
To pitch to Pureland Global Venture, founders should use the email address sasha.zeng@purelandventure.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team background. Founders should expect a response within a few weeks, depending on the volume of inquiries.
Warm introductions are preferred, but not mandatory. The firm values clear and concise communication regarding the startup's mission and impact.
In 2021, Pureland Global Venture participated in a GBP 18.45M Series B funding round for Leo Cancer Care, which focuses on upright radiotherapy solutions. This investment highlights the firm's commitment to supporting innovative medical technology.
Additionally, Pureland Global Venture invested in a $1.5M funding round for One Health Group, which specializes in clinically validated health analytics. This investment further demonstrates the firm's focus on enhancing healthcare delivery through technology.
What are Pureland Global Venture's investment criteria?
Pureland Global Venture focuses on early-stage medical technology companies, particularly in AI solutions and medical devices. The firm emphasizes affordability and effectiveness for emerging markets, improving clinical efficiency, and providing innovative therapeutic solutions.
How can I apply or pitch to Pureland Global Venture?
Founders can pitch their ideas via email at sasha.zeng@purelandventure.com. It is advisable to include a detailed deck outlining the business model, market opportunity, and team background.
What makes Pureland Global Venture different from other investors?
Pureland Global Venture distinguishes itself through its impact-driven investment strategy, focusing on enhancing patient care and addressing healthcare gaps in emerging markets. The firm also has a strong institutional backing from Enterprise Singapore, which enhances its credibility.
What is the geographic scope of Pureland Global Venture's investments?
The firm primarily invests in the Asia-Pacific region, India, and the United States, with a portfolio allocation of approximately 60% in the US and 40% in Singapore, India, and Europe.
What is the fund size and check size for investments?
While the specific fund size is not publicly disclosed, Pureland Global Venture typically invests in seed to Series A rounds. Check sizes vary based on the stage and needs of the startup.
What kind of post-investment involvement does Pureland Global Venture have?
The firm adds value to its portfolio companies by focusing on impact-driven strategies that enhance clinical workflows and patient care. The team leverages their expertise in medical technology to guide startups in achieving operational efficiency and market relevance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.